Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Other Specified Schizophrenia Spectrum and Other Psychotic Disorder”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Not applicableStudy completedNCT00919620
What this trial is testing

Stage-specific Case Management for Early Psychosis

Who this might be right for
Psychotic Disorders
The University of Hong Kong 360
Not applicableStudy completedNCT06007105
What this trial is testing

SUCCEED Africa: Support, Comprehensive Care and Empowerment of People With Psychosocial Disabilities

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizotypal Disorder+8 more
London School of Hygiene and Tropical Medicine 425
Not applicableStudy completedNCT01196286
What this trial is testing

Multifamily Psychoeducation and Cognitive Remediation for Recent-Onset Psychosis

Who this might be right for
Recent-Onset PsychosisSchizophreniaSchizoaffective Disorder+3 more
University of Arizona 40
Not applicableWithdrawnNCT02661347
What this trial is testing

Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia

Who this might be right for
SchizophreniaSchizophreniformSchizoaffective Disorder+1 more
Northwell Health
Early research (Phase 1)Study completedNCT00929955
What this trial is testing

Role of Anti-Inflammatory Agents in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderPsychosis Not Otherwise Specified+1 more
Pakistan Institute of Living and Learning 36
Testing effectiveness (Phase 2)Ended earlyNCT03230097
What this trial is testing

This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year

Who this might be right for
Psychotic Disorders
Boehringer Ingelheim 50
Not applicableStudy completedNCT00105118
What this trial is testing

Effect of Transcranial Magnetic Stimulation on Memory

Who this might be right for
HealthyHealthy VolunteerHV
National Institute of Mental Health (NIMH) 80
Post-approval studies (Phase 4)Ended earlyNCT00314327
What this trial is testing

Optimizing Response in Psychosis Study

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+1 more
Northwell Health 1
Not applicableLooking for participantsNCT03649581
What this trial is testing

Investigation of Neurophysiological Markers, Possibly Specific of Two Subforms of Psychotic Disorders

Who this might be right for
Schizophrenia
University Hospital, Strasbourg, France 84
Not applicableStudy completedNCT01570972
What this trial is testing

Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder With Psychotic Features+2 more
University of Arizona 103
Not applicableEnded earlyNCT01624831
What this trial is testing

Social Cognition in Longstanding Psychosis

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder With Psychotic Features+2 more
University of Arizona 9
Testing effectiveness (Phase 2)Study completedNCT00709202
What this trial is testing

Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+5 more
Nathan Kline Institute for Psychiatric Research 48
Post-approval studies (Phase 4)Ended earlyNCT00934635
What this trial is testing

A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy Controls

Who this might be right for
Schizophrenia
Janssen-Cilag G.m.b.H 2
Post-approval studies (Phase 4)Study completedNCT00320671
What this trial is testing

Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis

Who this might be right for
Schizophrenia
Northwell Health 198
Not applicableActive Not RecruitingNCT05756855
What this trial is testing

Young Adults With Violent Behavior During Early Psychosis (Aim 2)

Who this might be right for
SchizophreniaSchizo Affective DisorderSchizophreniform Disorders+2 more
Columbia University 15
Large-scale testing (Phase 3)Study completedNCT00300404
What this trial is testing

Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major Depression

Who this might be right for
SchizophreniaMajor Depression
Zentrum für Integrative Psychiatrie 40
Not applicableUnknownNCT04793438
What this trial is testing

Motive-specific Intervention for Negative Symptoms in Schizophrenia

Who this might be right for
Negative Type; SchizophrenicAnhedoniaApathy
University of Zurich 100
Not applicableStudy completedNCT01269710
What this trial is testing

Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+8 more
University of North Carolina, Chapel Hill 4
Not applicableEnded earlyNCT00617214
What this trial is testing

Schizophrenic Patients Taking Part in Integrated Care Program

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreni-form Disorder+2 more
AstraZeneca 20
Testing effectiveness (Phase 2)Study completedNCT01602029
What this trial is testing

Randomized Double Blind Placebo Control Study in Patients with Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderPsychosis Not Otherwise Specified+1 more
Pakistan Institute of Living and Learning 303
Load More Results